Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Shares Traded Last Trade
  +2.10p +17.14% 14.35p 5,339,690 16:29:07
Bid Price Offer Price High Price Low Price Open Price
14.10p 14.60p 14.85p 11.875p 12.25p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -1.93 -1.26 13.1

N4 Pharma (N4P) Latest News

More N4 Pharma News
N4 Pharma Takeover Rumours

N4 Pharma (N4P) Share Charts

1 Year N4 Pharma Chart

1 Year N4 Pharma Chart

1 Month N4 Pharma Chart

1 Month N4 Pharma Chart

Intraday N4 Pharma Chart

Intraday N4 Pharma Chart

N4 Pharma (N4P) Discussions and Chat

N4 Pharma Forums and Chat

Date Time Title Posts
12/11/201817:21N4 Pharma1,371
03/9/201814:34N4 Pharma - Making good drugs better.3,884

Add a New Thread

N4 Pharma (N4P) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:27:0114.4413,7131,980.16O
16:23:2914.4969,0139,999.98O
16:22:4414.045,000701.75O
16:22:3114.118,4131,187.07O
16:20:3414.1524,8163,511.99O
View all N4 Pharma trades in real-time

N4 Pharma (N4P) Top Chat Posts

DateSubject
12/11/2018
08:20
N4 Pharma Daily Update: N4 Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 12.25p.
N4 Pharma has a 4 week average price of 4.63p and a 12 week average price of 3.35p.
The 1 year high share price is 35.50p while the 1 year low share price is currently 3.35p.
There are currently 90,962,537 shares in issue and the average daily traded volume is 2,631,058 shares. The market capitalisation of N4 Pharma is £13,053,124.06.
12/11/2018
04:34
hughwilson: featherby81 As much as it pains me to walk away from a fight, I do understand where you are coming from. You may have noted from a few posts back where I said that as much of the positive news for N4 was now near term that I was inclined to let the company news do the talking. In my opinion the news for N4 is going to be highly positive in the near term and that will result in a share price that is many multiples of where we are now in due course, so for the time being I will play it your way and resist from posting and allow the debate to focus on all the near term news which I expect will be highly positive for the company and its share price. And to end, no I am not David Farier, nor for Lewis did I ever say I was , but I am aware of his business activities in turnaround situations like this from which he is normally very successful. Just something else the mob got wrong.
11/11/2018
15:28
hughwilson: What I would like to see is an apology from all those posters who have been trying to deramp this stock during its time of uncertainty. Deramping by spreading lies and fear for their own personal gain to the detriment of real investors (myself included), that is the apology that I would like to see but that has about as much chance of platting fog. Lewis, I am confident in your ability in such a way that if I ever said will be an easy tweak then you would have found it. The fact that you have not been able to proves that it does not exist which is what I said and makes you a filthy liar along with all the other things you claim I said and did not. Your inability to prove to the contrary shows you up for the hateful vendetta that you have been waging against my person. In my opinion along with other investors is that it is time to move on from these personal vendetta`s. Given the vile and defamatory remarks I have suffered on this board I have more to be aggrieved about than most and yet my main interest remains the future of N4 which I see as being very positive with a share price of many multiples of where we are now. The future is looking extremely bright for N4 and that is now being recognized in the press and the share price. hTTps://www.thisismoney.co.uk/money/investing/article-6372161/SMALL-CAP-MOVERS-MySQUAR-edge-collapse-uncovering-900k-unauthorised-payments.html
10/11/2018
15:35
hughwilson: So getting back to the point, does this sound like a deal is being discussed and that a deal is likely within the next three months? That question goes out to all except Lewis because he is just a Hugh hater. If you agree that there is a real chance of a deal then in your experience what is the effect on the share price when a minoe like N4 signs a deal with a major like AZ? "agreeing terms for co-development of an optimized version of Nuvec(R) under an appropriate collaboration agreement." In my experience, we have seen rises of 200-300% even before the market opens. Who knows what will happen here but as I said before, AZ are not the only company that N4 are in discussion with. If you accept that interest in Nuvec is building then you know where the share price is heading.
10/11/2018
12:21
hughwilson: There is a post on twitter which I will share because it sums up the reality at this time. Thanks to the poster. #N4P - "I firmly believe that by focusing our resources on Nuvec® we are in fact giving N4 Pharma the greatest chance to achieve multiple commercial opportunities given the revised risk profile we faced with our generics division following the data obtained from our clinical trial." It was a change in the risk profile which led to the closure of the generics division but in doing so Nigel was giving Nuvec the best chance of success and multiples of today's share price.
27/9/2018
09:45
ch1rp: At current mcap, and in light of recent deals in this subsector, it's really not unreasonable to suggest that a single (and entirely realistic) RNS could see the share price do multiples.Market needs educating on this.Aim Chaos on Twitter:)))Buy when no confidence and share price low, not on the day the news arrives:)))
07/9/2018
15:45
artyth2: OK, so Nigel isn't allowed to give us any "insider information" We are not asking for any. But, where is he hiding? Why no statements.?......"everything going to plan or not", whatever. I've basically written Sildenafil off, so any comeback is a bonus, but Nuvec, surely we deserve some loose statements as to how its fairing, without breaching any protocol. He was very quick to allow information out to smash the share price but seems loath to help get the share price back on its feet. Second hand info, spoon fed from Mr Hugh Wilson, aka David Farrier and Aim Chaos, aka Myles Mcnulty isn't good enough.
10/8/2018
12:19
jimbobaroony: Hugh, back in Feb when you were very bullish over N4P you accused me of deramping and posting "negative dribble". See below; "hughwilson7 Feb '18 - 20:12 - 1835 of 3883 As I said before, the Sildenafil is a reformulation of a proven drug to make it better. There is no basis for thinking N4's Viagra will be anything but successful. hughwilson7 Feb '18 - 21:53 - 1851 of 3883 The company itself is very bullish on its prospects. The company is ahead of its own timescales. It is already doing deals with the biggest pharmas in the world while being recognised snd funded by the British government. There are no negatives that I can see here and yet you spout nothing else but unsuported negative dribble. Don't pretend to be anything else (but a deramper)." This was becase I dared post the following suggesting that either could hammer the share price. "jimbobaroony 7 Feb '18 - 20:59 - 1843 of 3883 Edit For some yin to all your yang. Another catalyst (to drive share price).... - Delays / problems with their products - No deal announcements Pretty sure this is unlikely but its a possibility." I don't know how you can have the audacity to call us stupid!!! I am not in any way gloating at what has transpired (i am underwater here), however, it was always a possibility. Either you were too blind to see it, or didn't care as you had another agenda. Its one or the other!
03/2/2018
08:53
nick2412: Hugh, I guess the wording translates as MedImmune / AZ have the right to discuss and seek exclusivity whilst N4P retain the right to name their price. I think it would require a very large initial milestone payment for an exclusive license, or, alternatively, necessitate buying Nuvac outright for a sum that equates in the N4P share price to pounds rather than pence for AZ (or any other company for that matter) to achieve exclusivity. The studiy highlighting the differences between Nuvac and current / other DNA /RNA drug delivery methods should be published this quarter and perhaps before the Japan visit. Existing findings suggest that Nuvac will be in demand so the potential is a)a lucrative exclusive deal with AZ b) multiple licensing deals with different partners c) a bidding war to buy Nuvac outright. Early days but it's looking interesting to say the least.
03/7/2017
17:23
bdog51: I'm with you on that Flash. When the direction of travel reverses, the N4P share price can really motor. Bargain price down at these low levels right now. Just takes a bit of news flow to change the tide.
18/5/2017
11:50
someuwin: CEO owns 17% of the equity here. This is almost entirely from his own purchases on the market when this was ONZ (see repeated Holdings RNSs last year). Furthermore his consideration shares resulting from the new N4P listing are deferred until the N4P share price has been over 15p for 10 consecutive days. ...I don't think it will be too long before that situation occurs.
N4 Pharma share price data is direct from the London Stock Exchange
add chat code
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20181112 18:20:02